Status:
UNKNOWN
Local Effects of Amino Acids and 3-hydroxybutyrate in the Bilaterally Perfused Human Leg
Lead Sponsor:
University of Aarhus
Conditions:
Critical Illness
Protein Metabolism
Eligibility:
MALE
21-50 years
Phase:
NA
Brief Summary
Introduction: Protein loss during critical illness is an important problem and is shown to predict overall survival. In animal studies, infusion of leucine is shown to increase the synthesis of muscle...
Eligibility Criteria
Inclusion
- BMI between 19 and 28
- Written consent before study start
Exclusion
- Diabetes
- Inclusion in other studies using ionizing radiation.
- Allergic to egg or soy
Key Trial Info
Start Date :
September 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2016
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT01461603
Start Date
September 1 2011
End Date
July 1 2016
Last Update
March 3 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
M-researchlab. MEA, Aarhus University Hospital, NBG
Aarhus C, Denmark, 8000